„Focusing on IL-6/STAT3 Pathway shows the approach of anti-IL-6 antibody (tocilizumab) in the treatment of multiple hydrocephalus“ (2021) Current Opinion, 1(01), S. 15–19. Verfügbar unter: https://currentopinion.be/index.php/co/article/view/14 (Zugegriffen: 11 Oktober 2026).